Author Correction: Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma

• Jing Hao,
• Xiangzi Han,
• Haidong Huang,
• Xingjiang Yu,
• Jiankang Fang,
• Jianjun Zhao,
• Richard A. Prayson,
• Shideng Bao,
• Jennifer S. Yu

Affiliations

Jing Hao

Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic

Xiangzi Han

Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic

Haidong Huang

Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic

Xingjiang Yu

Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic

Jiankang Fang

Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic

Jianjun Zhao

Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic

Richard A. Prayson

Department of Anatomic Pathology, Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic

Shideng Bao

Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic

Jennifer S. Yu

Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic